Published in Thromb Haemost on April 07, 1987
Multiple adhesins of streptococci. Infect Immun (1992) 2.30
Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun (1990) 1.81
Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies. Infect Immun (1995) 1.04
Platelet-interactive products of Streptococcus sanguis protoplasts. Infect Immun (1990) 0.93
Ecto-5'-nucleotidase: a candidate virulence factor in Streptococcus sanguinis experimental endocarditis. PLoS One (2012) 0.90
A streptococcal adhesion system for salivary pellicle and platelets. Infect Immun (1998) 0.82
Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences. Infect Immun (1998) 0.79
Altered expression of the platelet aggregation-associated protein from Streptococcus sanguis after growth in the presence of collagen. Infect Immun (1995) 0.79
The thrombotic potential of oral pathogens. J Oral Microbiol (2009) 0.75
Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology (1999) 5.34
Images in clinical medicine. Heparin-induced skin necrosis. N Engl J Med (1996) 3.30
Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun (1978) 3.12
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem (1991) 2.82
Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med (1996) 2.38
Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell (1998) 2.34
Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (1986) 2.31
Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease. Nat New Biol (1972) 2.30
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost (2009) 2.14
Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood (2000) 2.12
Inherited thrombophilia: Part 1. Thromb Haemost (1996) 2.00
Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol (1990) 2.00
Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism. A randomized controlled trial. Ann Intern Med (1995) 1.93
Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood (1998) 1.88
Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun (1990) 1.81
Graft-versus-myeloma effect in two cases. Lancet (1996) 1.80
Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun (1983) 1.73
von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood (1999) 1.62
Structure-function relationship of human von Willebrand factor. Blood (1987) 1.60
Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. Arteriosclerosis (1989) 1.57
Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med (1991) 1.56
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation (1999) 1.54
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. Stroke (1993) 1.54
Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond) (1999) 1.54
Concordance of phenprocoumon dosage in married couples. BMJ (1997) 1.51
Point mutations regarded as missense mutations cause splicing defects in the factor XI gene. J Thromb Haemost (2011) 1.46
Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation (2000) 1.45
Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis (1993) 1.45
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med (1983) 1.44
[Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary]. Ned Tijdschr Geneeskd (2003) 1.42
How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis (2001) 1.41
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest (1985) 1.40
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
[Thrombotic thrombocytopenic purpura: a benign disease with a very severe acute phase]. Ned Tijdschr Geneeskd (1990) 1.39
Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews. Am J Hum Genet (1999) 1.38
The role of collagen in thrombosis and hemostasis. J Thromb Haemost (2004) 1.38
Inherited thrombophilia: Part 2. Thromb Haemost (1996) 1.34
Improved multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans, Bacteroides forsythus, and Porphyromonas gingivalis. J Clin Microbiol (1999) 1.34
Sequential regulation of the small GTPase Rap1 in human platelets. Mol Cell Biol (2000) 1.32
The hemostatic plug. Semin Hematol (1977) 1.31
Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost (1978) 1.30
Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate. J Lab Clin Med (1978) 1.30
Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia. Ann Intern Med (1981) 1.29
Combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis. Circulation (2003) 1.28
Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood (1991) 1.28
Inherited platelet disorders. Haemophilia (2012) 1.27
The origin of P-selectin as a circulating plasma protein. Thromb Haemost (1997) 1.25
Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest (1994) 1.23
Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect Immun (2001) 1.23
A new method to study shape recovery of red blood cells using multiple optical trapping. Biophys J (1995) 1.23
Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood (1983) 1.23
Calprotectin expression by gingival epithelial cells. Infect Immun (2001) 1.22
Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood (1994) 1.21
Mutation analysis of patients with Hermansky-Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. Am J Hum Genet (1998) 1.20
Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure (1997) 1.20
Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood (1986) 1.20
The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol (1986) 1.20
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood (1987) 1.18
Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions. Blood (1997) 1.17
A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thromb Haemost (1984) 1.17
Association between cigarette smoking, bacterial pathogens, and periodontal status. J Periodontol (1993) 1.17
The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood (1995) 1.16
A collagen-like immunodeterminant on the surface of Streptococcus sanguis induces platelet aggregation. J Immunol (1987) 1.16
Evidence for the covalent linkage of carbohydrate polymers to a glycoprotein from Streptococcus sanguis. J Biol Chem (1993) 1.16
Cell-free released components of Streptococcus sanguis inhibit human platelet aggregation. Infect Immun (1983) 1.15
Streptococcal reporter gene-fusion vector for identification of in vivo expressed genes. Plasmid (1999) 1.15
Multiplex PCR using conserved and species-specific 16S rRNA gene primers for simultaneous detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. J Clin Microbiol (1996) 1.15
Carrier frequency of the IVS4 + 4 A-->T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood (1995) 1.15
Structural studies on the O-linked carbohydrate chains of human platelet glycocalicin. Eur J Biochem (1984) 1.14
Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun (2001) 1.14
Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med (1970) 1.14
Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost (1988) 1.14
Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis (2004) 1.13
Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem (1997) 1.12
Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1. Blood (1997) 1.12
The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci U S A (1991) 1.12
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells. Arteriosclerosis (1986) 1.12
Thrombin stimulates glucose transport in human platelets via the translocation of the glucose transporter GLUT-3 from alpha-granules to the cell surface. J Cell Biol (1997) 1.12
Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. J Biol Chem (1990) 1.12
Risk factors associated with postpartum ovarian vein thrombosis. Thromb Haemost (1999) 1.11
Hemostasis in menstrual endometrium: a review. Obstet Gynecol Surv (1982) 1.11
Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology (2001) 1.11